4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-25-005864
SVP, Chief Accounting Officer sold 1,562 shares at $9.15 ($14,291)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sabatini Brent SVP, Chief Accounting Officer | 2025-02-13 | Sale 10b5-1 | −1,562 | $9.15 | $14,291 | 28,189 | D |
| Open-market sales · 1,562 sh · avg $9.15 · $14,291 | |||||||
Loading xslF345X05/wk-form4_1739576505.xml…